{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:18:38Z","timestamp":1783520318051,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20QNPY077"],"award-info":[{"award-number":["20QNPY077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000674"],"award-info":[{"award-number":["32000674"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901139"],"award-info":[{"award-number":["81901139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171189"],"award-info":[{"award-number":["82171189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.neuropharm.2022.109383","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:04:47Z","timestamp":1671620687000},"page":"109383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A role of GABAA receptor \u03b11 subunit in the hippocampus for rapid-acting antidepressant-like effects of ketamine"],"prefix":"10.1016","volume":"225","author":[{"given":"Xiao-Hui","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Gang","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Yu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yu","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Fang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109383_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nbd.2016.01.012","article-title":"Behavioral profiling as a translational approach in an animal model of posttraumatic stress disorder","volume":"88","author":"Ardi","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109383_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109383_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/B978-008045046-9.01240-7","article-title":"GABA synthesis and metabolism","author":"Behar","year":"2009","journal-title":"Encyclopedia Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/232105","article-title":"Astrocyte-synapse structural plasticity","author":"Bernardinelli","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2022.109383_bib6","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/cne.24665","article-title":"Cell type-specific distribution of GABA(A) receptor subtypes in the mouse dorsal striatum","volume":"527","author":"Boccalaro","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109383_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuint.2009.01.020","article-title":"A novel mechanism for GABA synthesis and packaging into synaptic vesicles","volume":"55","author":"Buddhala","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2022.109383_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2015.01.018","article-title":"Antidepressant dose of taurine increases mRNA expression of GABAA receptor \u03b12 subunit and BDNF in the hippocampus of diabetic rats","volume":"283","author":"Caletti","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109383_bib9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nm.3162","article-title":"Astrocyte-derived ATP modulates depressive-like behaviors","volume":"19","author":"Cao","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109383_bib10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.biopsych.2011.11.006","article-title":"(1)H-[(1)(3)C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism","volume":"71","author":"Chowdhury","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib11","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/sj.npp.1300982","article-title":"Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment","volume":"31","author":"Cz\u00e9h","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109383_bib12","series-title":"Hormones of the Limbic System, in Vitamins & Hormones","first-page":"1","article-title":"Models of depression","author":"Duman","year":"2010"},{"key":"10.1016\/j.neuropharm.2022.109383_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109383_bib14","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s11064-012-0766-5","article-title":"Roles of glutamine synthetase inhibition in epilepsy","volume":"37","author":"Eid","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2022.109383_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib16","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib17","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of Alpha5-containing GABAA receptors","volume":"40","author":"Fischell","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109383_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2005.11.005","article-title":"Glutamate- and GABA-based CNS therapeutics","volume":"6","author":"Foster","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109383_bib19","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1073\/pnas.1414728112","article-title":"Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions","volume":"112","author":"Fuchikami","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109383_bib20","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1523\/JNEUROSCI.3948-16.2017","article-title":"Erbb4 deletion from medium spiny neurons of the nucleus accumbens core induces schizophrenia-like behaviors via elevated GABA(A) receptor \u03b11 subunit expression","volume":"37","author":"Geng","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpsychires.2018.08.015","article-title":"Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: a systematic review and meta-analysis","volume":"105","author":"Godfrey","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109383_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2022.109383_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109383_bib24","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1038\/tp.2016.8","article-title":"Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study","volume":"6","author":"Hashimoto","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109383_bib25","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jad.2021.03.073","article-title":"Real-world evidence from a European cohort study of patients with treatment resistant depression: treatment patterns and clinical outcomes","volume":"290","author":"Heerlein","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109383_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-319-45096-4_2","article-title":"Glucose, Lactate, \u03b2-Hydroxybutyrate, acetate, GABA, and succinate as substrates for synthesis of glutamate and GABA in the glutamine-glutamate\/GABA cycle","volume":"13","author":"Hertz","year":"2016","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109383_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-022-01081-7","article-title":"Antidepressant effects of cherry leaf decoction on a chronic unpredictable mild stress rat model based on the Glu\/GABA-Gln metabolic loop","author":"Jiang","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2022.109383_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/6344","article-title":"Synaptic corelease of ATP and GABA in cultured spinal neurons","volume":"2","author":"Jo","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.pharep.2017.03.001","article-title":"Antidepressant, anticonvulsant and antinociceptive effects of 3'-methoxy-6-methylflavone and 3'-hydroxy-6-methylflavone may involve GABAergic mechanisms","volume":"69","author":"Karim","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2022.109383_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173531","article-title":"GABA(B) receptor intracellular signaling: novel pathways for depressive disorder treatment?","volume":"885","author":"Korczak","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109383_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2010_108","article-title":"Animal models of depression: molecular perspectives","volume":"7","author":"Krishnan","year":"2011","journal-title":"Curr. Top Behav. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2022.109383_bib33","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib34","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2022.02.014","article-title":"The ATP level in the medial prefrontal cortex regulates depressive-like behavior via the medial prefrontal cortex-lateral habenula pathway","volume":"92","author":"Lin","year":"2022","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2015.83","article-title":"A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder","volume":"21","author":"Milak","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib37","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109383_bib38","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib39","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","article-title":"Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies","volume":"24","author":"Moriguchi","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib40","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib41","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0154","article-title":"Astrocytic control of synaptic function","volume":"372","author":"Papouin","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5498\/wjp.v8.i2.51","article-title":"Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders","volume":"8","author":"Parkin","year":"2018","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/PEP-14097","article-title":"Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies","volume":"3","author":"Parviz","year":"2014","journal-title":"J. Pediatr. Epilepsy"},{"key":"10.1016\/j.neuropharm.2022.109383_bib44","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109383_bib45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2174\/13894501113149990156","article-title":"Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue","volume":"14","author":"Rajkowska","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2022.109383_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2017.09.013","article-title":"Neurosteroid dehydroepiandrosterone improves active avoidance retrieval and induces antidepressant-like behavior in rats","volume":"660","author":"Samardzic","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109383_bib47","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41583-021-00540-x","article-title":"The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders","volume":"23","author":"Sanacora","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib49","article-title":"Gamma-aminobutyric acid (GABA)","author":"Sapse","year":"2009","journal-title":"Encyclopedia Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.637863","article-title":"Glutamate and GABA homeostasis and neurometabolism in major depressive disorder","volume":"12","author":"Sarawagi","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jep.2014.12.070","article-title":"GABAA\/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa","volume":"162","author":"Sollozo-Dupont","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109383_bib52","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0306-4522(97)00146-2","article-title":"GABA(A) receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits","volume":"80","author":"Sperk","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109383_bib53","article-title":"Ketamine alters functional plasticity of astroglia: an implication for antidepressant effect","volume":"11","author":"Stenovec","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.neuropharm.2022.109383_bib54","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109383_bib55","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1038\/tp.2016.21","article-title":"Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model","volume":"6","author":"Sun","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109383_bib56","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1039\/C7FO01045A","article-title":"Quality components and antidepressant-like effects of GABA green tea","volume":"8","author":"Teng","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.neuropharm.2022.109383_bib57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000111299","article-title":"Effect of antidepressants on ATP content, 3H-valine incorporation and cell morphometry of astrocytes cultured from rat brain","volume":"17","author":"Trzeciak","year":"1995","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2010.10.009","article-title":"Antidepressant-like properties of \u03b12-containing GABAA receptors","volume":"217","author":"Vollenweider","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109383_bib59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12031-014-0277-8","article-title":"Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine","volume":"54","author":"Wang","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109383_bib60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2017.01.015","article-title":"Involvement of lateral habenula \u03b11 subunit-containing GABA(A) receptor-mediated inhibitory transmission in the regulation of depression-related behaviors in experimental Parkinson's disease","volume":"116","author":"Wang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109383_bib61","doi-asserted-by":"crossref","first-page":"24357","DOI":"10.18632\/aging.202249","article-title":"A forced swim-based rat model of premenstrual depression: effects of hormonal changes and drug intervention","volume":"12","author":"Wei","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuropharm.2022.109383_bib62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2018.11.007","article-title":"A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate\/GABA neurotransmitter systems","volume":"24","author":"Wilkinson","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2022.109383_bib63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ptr.6812","article-title":"Rapid antidepressant-like effect of Fructus Aurantii depends on cAMP-response element binding protein\/Brain-derived neurotrophic facto by mediating synaptic transmission","volume":"35","author":"Wu","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.neuropharm.2022.109383_bib64","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109383_bib65","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109383_bib66","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib67","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A negative allosteric modulator for \u03b15 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2022.109383_bib68","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109383_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109383_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109305","article-title":"Ketamine and its metabolites: Potential as novel treatments for depression","volume":"222","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109383_bib71","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12035-014-8798-2","article-title":"Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration","volume":"51","author":"Zhou","year":"2015","journal-title":"Mol. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:22:22Z","timestamp":1758439342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822004427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":71,"alternative-id":["S0028390822004427"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109383","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role of GABAA receptor \u03b11 subunit in the hippocampus for rapid-acting antidepressant-like effects of ketamine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109383"}}